Mark Smith, MD
Orthopaedic Surgery · Louisville, KYNPI 1447245758
Payments from drug & device makers
Across 64 payments — averaging $248.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$10K
- Alpha Orthopedic Systems$3K
- Arthrex$1K
- Smith+Nephew$407
- Blue Surgical LLC$358
- Exactech, Inc.$261
- plus $789 from 11 others
Across 1 payment — averaging $16.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$16
What the payments were for
- Royalty or licence$6,16239%
- Consulting fees$3,50022%
- Travel & lodging$6524%
- Food & beverage$3,39921%
- Education$2,19214%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 7 | $9,988 |
| Alpha Orthopedic Systems | 11 | $2,949 |
| Arthrex | 14 | $1,152 |
| Smith+Nephew | 8 | $407 |
| Blue Surgical LLC | 6 | $358 |
| Exactech, Inc. | 2 | $261 |
| Johnson & Johnson | 3 | $160 |
| Anika Therapeutics, Inc. | 1 | $158 |
| Encore Medical, LP | 1 | $130 |
| Zimmer Biomet | 1 | $107 |
| Stryker | 1 | $76 |
| Vericel Corporation | 3 | $59 |
| Pfizer | 2 | $39 |
| Bioventus LLC | 1 | $16 |
| Bone Support Inc. | 1 | $16 |
| Pacira Therapeutics, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,905 in reported general payments places this provider in the 70th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 198 | $2,425 |
| Celecoxib | 17 | $380 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $360 |
| Gabapentin | 23 | $294 |
| Mupirocin | 57 | $217 |
| Promethazine Hcl | 91 | $172 |
| Meloxicam | 25 | $148 |
| Methylprednisolone | 27 | $132 |
| Tramadol Hcl | 41 | $126 |
| Amoxicillin | 108 | $106 |
| Clindamycin Hcl | 19 | $15 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Louisville
- Arthur MalkaniLouisville$9.9M
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.6M
- Akbar NawabLouisville$1M
- Joseph GreeneLouisville$584K
- Rodolfo Zamora RendichLouisville$539K
- Tyler KellerLouisville$401K
- Madhusudhan YakkantiLouisville$360K
- Kevin HarreldLouisville$313K
- George QuillLouisville$304K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.